Establishes tianeptine as Schedule II controlled dangerous substance.
Sponsored By: Troy Singleton (Democratic), Douglas J. Steinhardt (Republican)
Failed
Personalized for You
How does this bill affect your finances?
Personalize government policy and PRIA will tell you what this bill means for your household, plus every other piece of legislation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Bill Overview
No Economic Impacts Identified for this Bill
Sponsors & Cosponsors
Sponsors
Troy Singleton
Democratic • Senate
Douglas J. Steinhardt
Republican • Senate
Cosponsors
Paul D. Moriarty
Democratic • Senate
Roll Call Votes
No roll call votes available for this bill.
Actions Timeline
WITHDRAWN, Approved by Governor — P.L.2025, c.249.
1/13/2026SenateIntroduced, 1st Reading in Senate, Referred to Senate Judiciary Committee
1/13/2026Senate
Bill Text
As Introduced
12/2/2025
Related Bills
A4844, Establishes "Targeted Midwifery Workforce Development Act"; appropriates $12 million.
A4836, Exempts certain portable solar generation devices from interconnection, net metering, and other requirements; requires DCA to amend or supplement State Uniform Construction Code concerning use of portable solar generation devices.
A4867, Establishes toll free helpline for first responders, health care workers, and other frontline workers experiencing post-traumatic stress disorder.
A4871, Allows gross income tax deduction for charitable contributions made to nonprofit entities supported by State funds or subsides.
A4856, Expands liability of certain individuals associated with limited liability companies and other commercial entities, when acting as residential landlord.
A4872, "End the Toll Trap Act"; concerns toll violations and related administrative fees; establishes "New York and New Jersey Toll and Fee Reduction Task Force."